UnknownNot Applicable

Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder

Turkey (Türkiye)40 participantsStarted 2023-01-01

Plain-language summary

In this study is the first prospective trial that compares the efficacy of TTNS in antimuscarinic naive and refractory women with idiopathic OAB. In this study, it was aimed to compare the effectiveness of TTNS on quality of life (QoL) and clinical parameters related to OAB in antimuscarinic naive and refractory women. The results of this study would make it easier to understand the place of TTNS among the treatment options in women with idiopathic OAB.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Women 18 years and older with clinically idiopathic OAB
✓. Having the ability to give written informed consent
✓. Ability to understand procedures

Exclusion criteria

✕. Presence of active vaginal or urinary tract infection or malignancy
✕. Pregnancy or intention to become pregnant during the study
✕. History of neurogenic bladder, peripheral or central neurological pathology
✕. Presence of Grade 2 and higher pelvic organ prolapse (POP) according to the International Continence Society (ICS)
✕. Having undergone urogynecological surgery in the last 3 months
✕. Women with stress urinary incontinence
✕. History of PTNS and/or TTNS for OAB in the past 6 months
✕. Presence of a pacemaker or implanted defibrillator

What they're measuring

İmprovement in incontinence episodes

Timeframe: 6 months

Trial details

NCT IDNCT05668715

SponsorPamukkale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More Urinary Bladder, Overactive trials